John Stanley Gibson

John Stanley Gibson

Auto-generated profile, based on publicly available information

John Stanley Gibson

Department of Veterinary Medicine, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2019 in IEEE Transactions on Antennas and Propagation
Verified
Journal Article
Open access
YSYousuf Shafiq
Yousuf Shafiq
JGJohn S. Gibson
John S. Gibson
HKHyun Kim
Hyun Kim
CACedric P. Ambulo
Cedric P. Ambulo
TWTaylor Ware
Taylor Ware
SGStavros Georgakopoulos
Stavros Georgakopoulos
A new passive RFID temperature sensor is presented for monitoring the temperature of the surrounding environment of perishable goods, such as, foods and medicines, in the cold supply chain. Specifically, this sensor self-tunes between 902 MHz and 928 MHz, operating in the RFID UHF band, as the temperature rises or falls beyond a certain threshold. The novelty of this passive sensor is its ability to operate through multiple high/low temperature cycles. The design consists of a planar dipole antenna with a customized Integrated T-match Network (ITMN) that is actuated above a ground plane. The actuation shifts the operating frequency and is controlled by Liquid Crystal Elastomers (LCEs), which are programmable and reversible temperature dependent polymers. As a result, our design can be reconfigured to operate at various temperature ranges for which the LCE is designed to operate. Analysis is performed to examine the performance of the proposed sensor near practical items and when it is in close-proximity to an additional sensor with varying orientation. Finally, the sensor’s performance was validated through full-wave simulations using ANSYS HFSS and measurements. Both the simulation and measurements agreed well with theory.

3 April 2012 in The Journal of Physiology
Verified
Journal Article
Closed access
YMYuling Ma
Yuling Ma
DRDavid Rees
David Rees
JGJ. S. Gibson
J. S. Gibson
JEJ. C. Ellory
J. C. Ellory

30 October 2006 in Arthritis & Rheumatism
Verified
Journal Article
Closed access
PDF file
PMP. I. Milner
P. I. Milner
TFT. P. A. Fairfax
T. P. A. Fairfax
JBJ. A. Browning
J. A. Browning
RWR. J. Wilkins
R. J. Wilkins
JGJ. S. Gibson
J. S. Gibson

1 May 2002 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
JGJ.S. Gibson
J.S. Gibson
JEJ.C. Ellory
J.C. Ellory

13 August 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
HBHalima Al Balushi
Halima Al Balushi
AHAnke Hannemann
Anke Hannemann
DRDavid Rees
David Rees
JBJohn Brewin
John Brewin
JGJohn Stanley Gibson
John Stanley Gibson
Oxidative damage to red blood cells (RBCs) may contribute to pathogenesis of sickle cell anemia. Reducing the deleterious effects of oxidants by exposing RBCs to a number of antioxidants has been shown to have protective effects against lipid and protein peroxidation. We hypothesize that antioxidants may also have beneficial effects on the abnormal membrane permeability of sickle cells. Increased cation permeability of these cells encourages HbS polymerization by causing RBC dehydration and also leads to externalization of the prothrombotic aminophospholipid phosphatidylserine (PS). Three antioxidants with different mechanisms of action were investigated – dithiothreitol, N-acetylcysteine, and quercetin. All three were found to inhibit the main cation pathways responsible for dehydration – the deoxygenation-induced cation conductance (or Psickle), the Ca2+-activated K+ channel (or Gardos channel), and the K+-Cl− cotransporter. They also reduced Ca2+-induced PS exposure and hemolysis. Findings provide evidence for additional beneficial actions of antioxidants in maintenance of rheology and reducing vascular adhesion and further inform the rationale for their clinical use.

1 November 2015 in EBioMedicine
Verified
Journal Article
Open access
AHA. Hannemann
A. Hannemann
DRD.C. Rees
D.C. Rees
STS. Tewari
S. Tewari
JGJ.S. Gibson
J.S. Gibson
Sickle cell disease (SCD) in patients of HbSC genotype is considered similar, albeit milder, to that in homozygous HbSS individuals--but with little justification. In SCD, elevated red cell cation permeability is critical as increased solute loss causes dehydration and encourages sickling. Recently, we showed that the KCl cotransporter (KCC) activity in red cells from HbSC patients correlated significantly with disease severity, but that in HbSS patients did not. Two transporters involved in red cell dehydration, the conductive channels Psickle and the Gardos channel, behaved similarly in red cells from the two genotypes, but were significantly less active in HbSC patients. By contrast, KCC activity was quantitatively greater in HbSC red cells. Results suggest that KCC is likely to have greater involvement in red cell dehydration in HbSC patients, which could explain its association with disease severity in this genotype. This work supports the hypothesis that SCD in HbSC patients is a distinct disease entity to that in HbSS patients. Results suggest the possibility of designing specific treatments of particular benefit to HbSC patients and a rationale for the development of prognostic markers, to inform early treatment of children likely to develop more severe complications of the disease.